QuVa Pharma Recalls
38 recalls on record · July 13, 2016 to July 15, 2026 · Drugs
Recalls by year
16
18
19
20
22
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
July 15, 2026DrugsFDA
QuVa Pharma, Inc. recalls Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park On
Hazard: Failed Impurities/Degradation Specifications
November 5, 2025DrugsFDA
QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Vo
Hazard: Presence of Particulate Matter
April 2, 2025DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 mL (2 mg/mL), 100 ml in NS Yellow CADD FS
Hazard: Lack of Assurance of Sterility
April 2, 2025DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CA
Hazard: Lack of Assurance of Sterility
April 2, 2025DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD FS
Hazard: Lack of Assurance of Sterility
October 5, 2022DrugsFDA
QuVa Pharma, Inc. recalls oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Comp
Hazard: Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).
July 1, 2020DrugsFDA
QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded
Hazard: Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac
June 17, 2020DrugsFDA
QuVa Pharma, Inc. recalls oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 W
Hazard: Subpotent drug - Product did not contain drug.
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride 55 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Pa
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 1000 mcg/100 mL (10 mcg/mL) in 0.9% Sodium Chloride 100 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Pa
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL PCA Vial Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 10
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 2500 mcg/50 mL (50 mcg/mL) 50 mL bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Su
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 800 mcg/200 mL (4 mcg/mL) BUPivacaine HCl 0.1667% 333.4 mg/200 mL (1.667 mg/mL) in 0.9% Sodium Chloride 200 mL
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free, Rx, QuVA Pharma 1075 West Park
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 1000 mcg/20 mL (50 mcg/mL) 20 mL in 20 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive,
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg/100 mL (1 mg/mL) in 0.9% Sodium Chloride Preservative Fre
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.1% 200 mg/200 mL (1 mg/mL) in 0.9% Sodium Chloride 200 mL CADD, Pre
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 2000 mcg/100 mL (20 mcg/mL) in 0.9% Sodium Chloride, 100 mL Bag, Preservative Free, Rx, QuVA Pharma 1075 West P
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 400 mcg/200 mL (2 mcg/mL) 0.1% ROPivacaine HCl 200 mg/200 mL (1 mg/mL) in 0.9% Sodium Chloride , 200 mL bag, Pr
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride , 100 mL bag, Pr
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 250 mcg/5 mL (50 mcg/mL), 5 mL Syringe, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg/100 mL (1 mg/mL) in 0.9% Sodium Chloride 100 mL CADD Pres
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 2750 mcg/55 mL (50 mcg/mL) 55 mL Syringe, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 10
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 200 mcg/100 mL (2 mcg/mL) 0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL) in 0.9% Sodium Chloride, 100 mL CAD
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 100 mcg/2 mL (50 mcg/mL) Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, T
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 1000 mcg/100 mL (10 mcg/mL) in 0.9% Sodium Chloride Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.2% 400 mg/200 mL (2 mg/mL) in 0.9% Sodium Chloride 200 mL CADD Pres
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 2500 mcg/250 mL (10 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free, Rx, QuVA Pharma 1075 West Par
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 500 mcg/250 mL (2 mcg/mL) ROPivacaine HCl 0.2% 500 mg/250 mL (2 mg/mL) in 0.9% Sodium Chloride 250 mL Bag Rx, P
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
December 11, 2019DrugsFDA
QuVa Pharma, Inc. recalls fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL in 35 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive,
Hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules